Save Your Skin Foundation

Save Your Skin Foundation

October 01, 2014 11:00 ET

New Melanoma Research Presented at ESMO Brings Renewed Optimism to Canadian Melanoma Patients

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 1, 2014) - The Save Your Skin Foundation is pleased to learn about the new research coming out of the European Society for Medical Oncology (ESMO) conference that has better patient outcomes for those living with melanoma. Advanced research in precision medicines, such as Roche's coBRIM study presented earlier today at ESMO, are giving doctors more opportunities to ensure patients are receiving the right treatments by using a more targeted approach to medicine.

"We are very excited about the investigational research and the new approach for melanoma treatment presented at ESMO this year," said Kathy Barnard, Foundation President and Founder. "The coBRIM study looks at treating melanoma patients using a combination of targeted therapies instead of just one. This new precision medicine approach not only improves quality of life for patients, but also has the potential to save lives."

The coBRIM study looked at using the investigational MEK inhibitor cobimetinib in combination with Roche's BRAF inhibitor Zelboraf® (vemurafenib) to treat untreated BRAF V600 mutation-positive advanced melanoma in comparison to Zelboraf® alone. The study results showed a median progression-free survival of 9.9 months for cobimetinib plus Zelboraf compared to 6.2 months with Zelboraf alone.

The Save Your Skin Foundation will continue to follow the exciting research discussed at ESMO and will work with researchers as they continue to explore safe new ways to treat melanoma patients. By working together, patients will be helped through their journey with cancer.

About Melanoma in Canada

Every year, thousands of Canadians are diagnosed with melanoma, with the incidence of the disease increasing faster than that of any other cancer. Melanoma is a deadly form of skin cancer characterized by the uncontrolled growth of pigment-producing cells (melanocytes) located in the skin. One in 74 men and 1 in 90 women are expected to develop melanoma during their lifetime. Melanoma is clearly visible on the skin, and 90 per cent of melanomas are caused by exposure to UV light, including tanning beds.

About the Save Your Skin Foundation

The Save Your Skin Foundation is a Canadian not-for-profit foundation. Through events and other initiatives, the Foundation focuses on raising funds for education and awareness, providing emotional and financial support to those dealing with melanoma and non-melanoma skin cancers, and on supporting the ongoing research and treatment of skin cancer - especially melanoma.

For more information, please visit www.saveyourskin.ca.

Contact Information